Cabot Corporation (NYSE:CBT) Given Average Recommendation of “Hold” by Brokerages

Shares of Cabot Corporation (NYSE:CBTGet Free Report) have received an average rating of “Hold” from the seven research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $89.00.

A number of analysts have recently weighed in on the company. Truist Financial set a $100.00 price objective on Cabot in a research report on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a report on Friday, August 7th. UBS Group lowered their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, August 5th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Finally, Mizuho lifted their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th.

Check Out Our Latest Analysis on Cabot

Insider Buying and Selling at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold a total of 229,597 shares of company stock valued at $19,646,746 in the last quarter. Company insiders own 3.08% of the company’s stock.

Hedge Funds Weigh In On Cabot

Institutional investors and hedge funds have recently bought and sold shares of the business. Rothschild Investment LLC boosted its holdings in shares of Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Northwestern Mutual Wealth Management Co. acquired a new stake in Cabot during the second quarter worth about $33,000. Global Retirement Partners LLC increased its position in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S purchased a new stake in shares of Cabot during the 3rd quarter valued at approximately $38,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Performance

Shares of NYSE:CBT opened at $81.47 on Monday. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 22.95, a price-to-earnings-growth ratio of 10.70 and a beta of 0.83. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53. The firm has a 50 day moving average of $86.67 and a 200 day moving average of $81.44.

Cabot (NYSE:CBTGet Free Report) last issued its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same quarter last year, the company earned $1.90 earnings per share. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, sell-side analysts predict that Cabot will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is 53.24%.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.